Weill Cornell Medicine accuses BCBS of market allocation in US complaint

MLex Summary: Weill Cornell Medicine filed a US complaint accusing Blue Cross Blue Shield and its affiliates of illegally conspiring to divide the US into designated “service areas” and allocate those...

Already a subscriber? Click here to view full article